Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The study found that horizontal sections of scalp biopsies are better for analyzing hair loss, showing fewer hairs and more fine hairs in balding areas.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

PRP shows promise for treating hair loss but needs more research.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Vitamins B3, B6, C, and iron intake affect hormone levels in women with certain types of PCOS.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

PCOS involves high 11-oxygenated androgens and BPA may worsen it, while IH is not inflammatory.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.